RGD Reference Report - Antinociceptive potentiation and attenuation of tolerance by intrathecal {beta}-arrestin 2 small interfering RNA in rats. - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

Antinociceptive potentiation and attenuation of tolerance by intrathecal {beta}-arrestin 2 small interfering RNA in rats.

Authors: Yang, CH  Huang, HW  Chen, KH  Chen, YS  Sheen-Chen, SM  Lin, CR 
Citation: Yang CH, etal., Br J Anaesth. 2011 Nov;107(5):774-81. Epub 2011 Sep 17.
RGD ID: 5509871
Pubmed: PMID:21926413   (View Abstract at PubMed)
DOI: DOI:10.1093/bja/aer291   (Journal Full-text)

BACKGROUND: /st> Tolerance to the analgesic effect of opioids complicates the management of persistent pain states. We tested whether the intrathecal infusion of small interfering RNA (siRNA) against beta-arrestin 2 would reduce tolerance to chronic morphine use and the severity of precipitated morphine withdrawal. METHODS: /st> Intrathecal beta-arrestin 2 (2 mug siRNA per 10 mul per rat) was injected once daily for 3 days. Rats then received a continuous intrathecal infusion of morphine (2 nmol h(-1)) or saline for 7 days. Daily tail-flick (TF) and intrathecal morphine challenge tests were performed to assess the effect of intrathecal beta-arrestin 2 siRNA on antinociception and tolerance to morphine. Naloxone withdrawal (2 mg kg(-1)) was performed to assess morphine dependence. RESULTS: /st> In the daily TF test, the antinociception of intrathecal morphine was increased and maintained in rats receiving beta-arrestin 2 siRNA compared with the control group (morphine alone). In the probe response test, rats receiving morphine infusion with beta-arrestin 2 siRNA treatment showed a significant left shift in their dose-response curve, as measured by per cent maximal possible effect (MPE), such that the AD(50) was significantly decreased by a factor of 5.6 when compared with that of morphine-infused rats. In the naloxone-induced withdrawal tests, rats receiving beta-arrestin 2 siRNA injection with morphine infusion showed a significant reduction in four of the six signs of withdrawal. CONCLUSIONS: /st> We show here that intrathecal beta-arrestin 2 siRNA in rats enhances analgesia and attenuates naloxone-induced withdrawal symptoms. This may warrant further investigation in the context of long-term use of intrathecal opioids for controlling chronic pain.

Gene Ontology Annotations    Click to see Annotation Detail View

Biological Process
TermQualifierEvidenceWithReferenceNotesSourceOriginal Reference(s)
detection of temperature stimulus involved in sensory perception of pain  IMP 5509871 RGD 

Objects Annotated

Genes (Rattus norvegicus)
Arrb2  (arrestin, beta 2)


Additional Information